Galmed Pharmaceuticals Ltd.
GLMD
$1.45
$0.1259.47%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
5/6/2025
-
PR Newswire
5/2/2025
-
Ticker Report
5/1/2025
-
Ticker Report
4/29/2025
-
TipRanks Financial Blog
4/28/2025
-
GuruFocus
4/28/2025
-
TipRanks Financial Blog
4/28/2025
-
PR Newswire
4/23/2025
-
Ticker Report
4/17/2025
-
GuruFocus
4/17/2025
-
GuruFocus
4/17/2025
-
PR Newswire
4/15/2025
-
PR Newswire
4/10/2025
-
PR Newswire
4/2/2025
-
GuruFocus
4/2/2025
-
PR Newswire
3/30/2025
-
Ticker Report
3/28/2025
-
Ticker Report
3/20/2025
-
GuruFocus
3/20/2025
-
PR Newswire
3/19/2025
-
Ticker Report
3/15/2025
-
Ticker Report
2/10/2025
-
Ticker Report
1/31/2025
-
Ticker Report
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Wednesday, April 2, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 26 and 30 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
972 3 693 8448
Address
16 Abba Hillel Road
Ramat Gan, 5250608
Ramat Gan, 5250608
Country
Year Founded
Business Description
Sector
Galmed Pharmaceuticals Ltd., a biopharmaceutical company, focuses on the development of Aramchol for the treatment of liver diseases. It develops Aramchol, a first-in-class synthetic fatty...
more